Asked | Open questions | Answered
Date Pair Term Level Status Answers (undeclined) Gloss
Nov 19 '09 eng>fra adjunctive hemostasis agent pro closed 1 ok
Nov 18 '09 eng>fra University Teaching and/or Academic focus hospital pro closed 2 ok
Nov 18 '09 eng>fra active surgical bleeding pro open 2 no
Oct 13 '09 eng>fra travel discomfort and anxiety pro closed 4 no
Oct 12 '09 eng>fra (x) percent of normal pro closed 2 ok
Oct 12 '09 eng>fra range of reasonable opinion pro closed 4 ok
Oct 11 '09 eng>fra active bed pro closed 4 no
Oct 9 '09 eng>fra wasted blood pro open 1 no
Oct 9 '09 eng>fra flange pro closed 3 no
Oct 9 '09 eng>fra waste space (in a syringe) pro open 2 no
Oct 9 '09 eng>fra sterile IV compounding room pro closed 3 no
Oct 9 '09 eng>fra spike dispensing pin pro open 1 no
Oct 8 '09 eng>fra troubleshooting IVs for clots (clot removal with a syringe) pro open 3 no
Oct 8 '09 eng>fra Push into IV Bag (pump, drip, gravity) pro closed 2 no
Oct 8 '09 eng>fra Syringe pump infusion pro closed 1 ok
Oct 8 '09 eng>fra IV / IVPB push pro open 4 no
Sep 29 '09 eng>fra workhorse pro closed 3 ok
Sep 25 '09 eng>fra community clinic pro closed 4 ok
Sep 25 '09 eng>fra nuisance side effects pro closed 4 ok
Sep 25 '09 eng>fra Chemo doublet pro closed 2 no
Sep 24 '09 eng>fra regimen class pro closed 2 ok
Sep 24 '09 eng>fra Non-Squamous NSCLC pro closed 3 ok
Sep 1 '09 eng>fra skincare chemistry pro closed 6 no
Aug 26 '09 eng>fra human plasma-derived von Willebrand Factor-ristocetin co-factor activity pro just_closed 2 no
Aug 19 '09 eng>fra in the community pro closed 3 no
Aug 17 '09 rus>fra экспозиционнaя профилактикa pro closed 1 no
Aug 16 '09 rus>fra МНИИЭМ им. Г.Н. Габричевского pro closed 1 no
Aug 16 '09 rus>fra по стоимостному объему pro closed 4 ok
Aug 3 '09 eng>fra full time, patient based practice pro closed 4 no
Feb 25 '09 eng>fra patient load pro closed 2 ok
Oct 30 '08 eng>fra unrealized foreign exchange adjustments pro closed 3 ok
Oct 30 '08 eng>fra combination of interest income and fair market value adjustments pro closed 2 ok
Oct 23 '08 eng>fra exclusive royalty-bearing license pro closed 1 ok
Oct 18 '08 eng>fra back to back study pro closed 4 ok
Oct 18 '08 eng>fra interventionalist pro closed 3 ok
Oct 17 '08 eng>fra target-by-target basis pro closed 1 ok
Oct 17 '08 eng>fra one-time-license-fee pro closed 5 ok
Jul 26 '08 eng>fra (major/supporting) evidence statement pro closed 3 no
Jun 2 '08 eng>fra first commercial implantation (of a stent) pro closed 4 no
Jun 2 '08 eng>fra deliver(ed) / deliverability pro closed 4 ok
Jun 1 '08 eng>fra Tumor mutation products pro closed 2 ok
May 31 '08 eng>fra companion diagnostic pro closed 2 ok
May 30 '08 eng>fra demonstrate pharmacodynamic proof of concept pro closed 2 ok
May 30 '08 eng>fra present with or develop (metastatic disease) pro closed 3 ok
May 29 '08 eng>fra studies summary pro closed 3 ok
May 28 '08 eng>fra near-term milestones pro closed 2 ok
May 25 '08 eng>fra overcome the normal subconscious pro closed 3 ok
May 25 '08 eng>fra business case pro closed 2 no
May 24 '08 eng>fra absorptive gastrointestinal tract pro closed 4 ok
May 23 '08 eng>fra Key take-aways pro closed 4 ok
Asked | Open questions | Answered